NEKTAR THERAPEUTICS (NKTR)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue TTM

0 500M 1B 1.5B Q4 '10: 159M Q1 '11: 137.1M Q2 '11: 111.9M Q3 '11: 101M Q4 '11: 71.5M Q1 '12: 78.1M Q2 '12: 84.5M Q3 '12: 75.8M Q4 '12: 81.2M Q1 '13: 86.2M Q2 '13: 96.4M Q3 '13: 138.9M Q4 '13: 148.9M Q1 '14: 145.7M Q2 '14: 140.3M Q3 '14: 212.3M Q4 '14: 200.7M Q1 '15: 289.7M Q2 '15: 283.9M Q3 '15: 211M Q4 '15: 230.8M Q1 '16: 180.9M Q2 '16: 191M Q3 '16: 167.4M Q4 '16: 165.4M Q1 '17: 131.3M Q2 '17: 133.1M Q3 '17: 249.7M Q4 '17: 307.7M Q1 '18: 321M Q2 '18: 1.4B Q3 '18: 1.2B Q4 '18: 1.2B Q1 '19: 1.2B Q2 '19: 119.1M Q3 '19: 120.6M Q4 '19: 114.6M Q1 '20: 137M Q2 '20: 162.5M Q3 '20: 163.3M Q4 '20: 152.9M Q1 '21: 126M Q2 '21: 105.5M Q3 '21: 100.4M Q4 '21: 101.9M Q1 '22: 103.1M Q2 '22: 96.3M Q3 '22: 95M Q4 '22: 92.1M Q1 '23: 88.8M Q2 '23: 87.7M Q3 '23: 88.3M Q4 '23: 90.1M Q1 '24: 90.2M Q2 '24: 93.2M Q3 '24: 93.1M Q4 '24: 98.4M Q1 '25: 87.2M Q2 '25: 74.9M Q3 '25: 62.6M Q4 '25: 55.2M Q1 '26: 55.6M Q2 '26: 54.6M Q2 '12 Q2 '14 Q2 '16 Q2 '18 Q2 '20 Q2 '22 Q2 '24 Q2 '26

Gross Profit TTM

-1.5M 0 1.5M 3M 4.5M Q4 '10: 1.7M Q1 '11: 3.4M Q2 '11: -585K Q3 '11: 2.8M Q4 '11: 3M Q4 '10 Q1 '11 Q2 '11 Q3 '11 Q4 '11

Operating Income TTM

-700M -350M 0 350M 700M 1.1B Q4 '10: -28.3M Q1 '11: -58.8M Q2 '11: -94.9M Q3 '11: -110M Q4 '11: -123.9M Q1 '12: -128M Q2 '12: -120.7M Q3 '12: -132.3M Q4 '12: -141.2M Q1 '13: -148.4M Q2 '13: -154M Q3 '13: -127.6M Q4 '13: -120.1M Q1 '14: -111.4M Q2 '14: -101.7M Q3 '14: -14.9M Q4 '14: -16.5M Q1 '15: 63M Q2 '15: 42.4M Q3 '15: -37.5M Q4 '15: -29.4M Q1 '16: -81.9M Q2 '16: -76.8M Q3 '16: -110.1M Q4 '16: -112.9M Q1 '17: -157.8M Q2 '17: -170.1M Q3 '17: -67.8M Q4 '17: -59.6M Q1 '18: -91.9M Q2 '18: 932.3M Q3 '18: 764.2M Q4 '18: 687.9M Q1 '19: 654M Q2 '19: -430.6M Q3 '19: -430.7M Q4 '19: -440M Q1 '20: -453M Q2 '20: -419.7M Q3 '20: -424M Q4 '20: -425.1M Q1 '21: -400.9M Q2 '21: -433.4M Q3 '21: -443.9M Q4 '21: -446.1M Q1 '22: -453.3M Q2 '22: -495.9M Q3 '22: -436.6M Q4 '22: -376.2M Q1 '23: -394.3M Q2 '23: -292.1M Q3 '23: -282.6M Q4 '23: -263.7M Q1 '24: -164.4M Q2 '24: -163.6M Q3 '24: -153.1M Q4 '24: -105.2M Q1 '25: -114.3M Q2 '25: -100.8M Q3 '25: -98.1M Q4 '25: -140.1M Q1 '26: -134.6M Q2 '26: -140.7M Q2 '12 Q2 '14 Q2 '16 Q2 '18 Q2 '20 Q2 '22 Q2 '24 Q2 '26

Net Income TTM

-700M -350M 0 350M 700M 1.1B Q4 '10: -37.9M Q1 '11: -67.8M Q2 '11: -103.7M Q3 '11: -119.1M Q4 '11: -134M Q1 '12: -139M Q2 '12: -136.9M Q3 '12: -156.4M Q4 '12: -171.9M Q1 '13: -185.8M Q2 '13: -194.3M Q3 '13: -167.3M Q4 '13: -162M Q1 '14: -153.2M Q2 '14: -143M Q3 '14: -55.9M Q4 '14: -53.9M Q1 '15: 26.1M Q2 '15: 6.1M Q3 '15: -72.7M Q4 '15: -81.2M Q1 '16: -134.5M Q2 '16: -130.4M Q3 '16: -165.5M Q4 '16: -153.5M Q1 '17: -197.9M Q2 '17: -209.2M Q3 '17: -105.1M Q4 '17: -96.7M Q1 '18: -128.6M Q2 '18: 902.7M Q3 '18: 745.7M Q4 '18: 681.3M Q1 '19: 657.5M Q2 '19: -424.3M Q3 '19: -426.7M Q4 '19: -440.7M Q1 '20: -459.7M Q2 '20: -429.4M Q3 '20: -439.4M Q4 '20: -444.4M Q1 '21: -428.8M Q2 '21: -474.3M Q3 '21: -495.4M Q4 '21: -523.8M Q1 '22: -491.3M Q2 '22: -524.8M Q3 '22: -454.2M Q4 '22: -368.2M Q1 '23: -414.8M Q2 '23: -306.9M Q3 '23: -293.7M Q4 '23: -276.1M Q1 '24: -175.8M Q2 '24: -177.1M Q3 '24: -168.3M Q4 '24: -119M Q1 '25: -133M Q2 '25: -122.3M Q3 '25: -120.7M Q4 '25: -164.1M Q1 '26: -158.1M Q2 '26: -157.1M Q2 '12 Q2 '14 Q2 '16 Q2 '18 Q2 '20 Q2 '22 Q2 '24 Q2 '26

Cost of Revenue TTM

0 15M 30M 45M Q4 '17: 30.5M Q1 '18: 31.1M Q2 '18: 27.6M Q3 '18: 26.7M Q4 '18: 24.4M Q1 '19: 23.2M Q2 '19: 22.7M Q3 '19: 22.8M Q4 '19: 21.4M Q1 '20: 19.7M Q2 '20: 20.5M Q3 '20: 21.1M Q4 '20: 19.5M Q1 '21: 21.4M Q2 '21: 23.3M Q3 '21: 23.1M Q4 '21: 24.9M Q1 '22: 24.5M Q2 '22: 21.9M Q3 '22: 21.6M Q4 '22: 21.6M Q1 '23: 23.4M Q2 '23: 25.3M Q3 '23: 32.7M Q4 '23: 33.8M Q1 '24: 35.2M Q2 '24: 38M Q3 '24: 30M Q4 '24: 30.7M Q1 '25: 22.2M Q2 '25: 12.4M Q3 '25: 8M Q4 '25: 0 Q2 '18 Q3 '19 Q4 '20 Q1 '22 Q2 '23 Q3 '24 Q4 '25

Operating Cash Flow TTM

-700M -350M 0 350M 700M 1.1B Q4 '10: -55.9M Q1 '11: -36.6M Q2 '11: -51.4M Q3 '11: -51.1M Q4 '11: -113.7M Q1 '12: -133.5M Q2 '12: -119.3M Q3 '12: -124.6M Q4 '12: -129.8M Q1 '13: -133.2M Q2 '13: -147M Q3 '13: -139.5M Q4 '13: -38.5M Q1 '14: -62.7M Q2 '14: -37.5M Q3 '14: -63.7M Q4 '14: -142M Q1 '15: -16.4M Q2 '15: -54.6M Q3 '15: -22.6M Q4 '15: -73.1M Q1 '16: -160M Q2 '16: -126.4M Q3 '16: -139.7M Q4 '16: -117M Q1 '17: -127.9M Q2 '17: -172.9M Q3 '17: -52.4M Q4 '17: -80.4M Q1 '18: -98.3M Q2 '18: 919.9M Q3 '18: 755.4M Q4 '18: 718.2M Q1 '19: 689.8M Q2 '19: -323.8M Q3 '19: -321M Q4 '19: -328.7M Q1 '20: -325.9M Q2 '20: -355.8M Q3 '20: -339.9M Q4 '20: -313.3M Q1 '21: -312.3M Q2 '21: -311.3M Q3 '21: -359.8M Q4 '21: -412.7M Q1 '22: -424M Q2 '22: -416.1M Q3 '22: -397.8M Q4 '22: -304M Q1 '23: -267.5M Q2 '23: -244M Q3 '23: -203.3M Q4 '23: -192.6M Q1 '24: -188.6M Q2 '24: -174.8M Q3 '24: -176.6M Q4 '24: -175.7M Q1 '25: -176.9M Q2 '25: -184.9M Q3 '25: -189.7M Q4 '25: -208.5M Q1 '26: -203.8M Q2 '26: -233.8M Q2 '12 Q2 '14 Q2 '16 Q2 '18 Q2 '20 Q2 '22 Q2 '24 Q2 '26

Free Cash Flow TTM

-700M -350M 0 350M 700M 1.1B Q4 '10: -87.3M Q1 '11: -67.8M Q2 '11: -80.9M Q3 '11: -68.7M Q4 '11: -123.5M Q1 '12: -141M Q2 '12: -125.3M Q3 '12: -131.8M Q4 '12: -140.3M Q1 '13: -142.6M Q2 '13: -155.2M Q3 '13: -145.8M Q4 '13: -42.6M Q1 '14: -71M Q2 '14: -45.9M Q3 '14: -72.5M Q4 '14: -152M Q1 '15: -22.9M Q2 '15: -63.9M Q3 '15: -35.2M Q4 '15: -84.3M Q1 '16: -171.9M Q2 '16: -136.2M Q3 '16: -145.9M Q4 '16: -123.4M Q1 '17: -136.7M Q2 '17: -182.4M Q3 '17: -62.4M Q4 '17: -90.1M Q1 '18: -104.9M Q2 '18: 912.8M Q3 '18: 747.4M Q4 '18: 704M Q1 '19: 670.9M Q2 '19: -351.6M Q3 '19: -352.3M Q4 '19: -355M Q1 '20: -347.4M Q2 '20: -368.4M Q3 '20: -349.1M Q4 '20: -320.5M Q1 '21: -321.5M Q2 '21: -321.1M Q3 '21: -370.6M Q4 '21: -427.6M Q1 '22: -440.3M Q2 '22: -429.9M Q3 '22: -408.9M Q4 '22: -309.7M Q1 '23: -269.4M Q2 '23: -245.3M Q3 '23: -204.4M Q4 '23: -193.5M Q1 '24: -189.2M Q2 '24: -175.4M Q3 '24: -177.8M Q4 '24: -177.2M Q1 '25: -178.2M Q2 '25: -186.1M Q3 '25: -190.4M Q4 '25: -208.7M Q1 '26: -203.9M Q2 '26: -234M Q2 '12 Q2 '14 Q2 '16 Q2 '18 Q2 '20 Q2 '22 Q2 '24 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 70M 140M 210M Q3 '13: 115.8M Q1 '14: 123.5M Q3 '14: 132.2M Q1 '15: 135.7M Q3 '15: 132.6M Q1 '16: 135.8M Q3 '16: 137.1M Q2 '17: 155.4M Q3 '17: 162.6M Q2 '18: 182.3M Q3 '18: 172.7M Q2 '19: 174.5M Q3 '19: 175.4M Q2 '20: 178.3M Q3 '20: 179.1M Q1 '21: 181.4M Q2 '21: 182.7M Q3 '21: 184.1M Q1 '22: 185.8M Q2 '22: 186.8M Q3 '22: 187.6M Q1 '23: 188.9M Q2 '23: 189.7M Q3 '23: 190.4M Q1 '24: 194.7M Q2 '24: 13.9M Q3 '24: 13.9M Q1 '25: 14.1M Q2 '25: 14.1M Q3 '25: 18.9M Q1 '26: 24.7M Q2 '26: 33.1M Q1 '15 Q2 '17 Q2 '19 Q1 '21 Q2 '22 Q3 '23 Q1 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-900.00 -600.00 -300.00 0.00 300.00 600.00 900.00 Q4 '10: -0.41 Q1 '11: -0.67 Q2 '11: -0.98 Q3 '11: -1.10 Q4 '11: -1.19 Q1 '12: -1.22 Q2 '12: -1.20 Q3 '12: -1.37 Q4 '12: -1.50 Q1 '13: -1.62 Q2 '13: -1.69 Q3 '13: -1.45 Q4 '13: -1.40 Q1 '14: -1.29 Q2 '14: -1.18 Q3 '14: -0.51 Q4 '14: -0.45 Q1 '15: 0.17 Q2 '15: 0.03 Q3 '15: -0.56 Q4 '15: -0.61 Q1 '16: -1.00 Q2 '16: -0.96 Q3 '16: -1.22 Q4 '16: -1.10 Q1 '17: -1.38 Q2 '17: -1.41 Q3 '17: -0.72 Q4 '17: -0.65 Q1 '18: -0.83 Q2 '18: 4.89 Q3 '18: 3.96 Q4 '18: 3.60 Q1 '19: 3.51 Q2 '19: -2.45 Q3 '19: -2.45 Q4 '19: -2.52 Q1 '20: -2.61 Q2 '20: -2.43 Q3 '20: -2.48 Q4 '20: -2.49 Q1 '21: -2.39 Q2 '21: -2.63 Q3 '21: -2.72 Q4 '21: -792.07 Q1 '22: -791.88 Q2 '22: -792.04 Q3 '22: -791.65 Q4 '22: -1.97 Q1 '23: -2.21 Q2 '23: -1.63 Q3 '23: -1.56 Q4 '23: -1.46 Q1 '24: -0.92 Q2 '24: -4.41 Q3 '24: -6.83 Q4 '24: -8.68 Q1 '25: -12.11 Q2 '25: -11.30 Q3 '25: -10.51 Q4 '25: -10.03 Q1 '26: -8.23 Q2 '26: -6.51 Q2 '12 Q2 '14 Q2 '16 Q2 '18 Q2 '20 Q2 '22 Q2 '24 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.